Can Oral THC Pills Ease Marijuana Withdrawal? A Controlled Study Says Yes | Research

The takeaway

Oral THC capsules reduced marijuana craving, anxiety, sleep problems, and appetite loss during withdrawal without producing intoxication, while the mood stabilizer divalproex worsened mood and cognitive performance.

Read this if you are trying to quit heavy cannabis use and struggling with withdrawal symptoms.

Oral THC relieved 5 withdrawal symptoms without producing intoxication

What the researchers found

In two controlled studies with heavy marijuana users (6-10 joints per day), oral THC (10 mg five times daily) administered during marijuana abstinence decreased anxiety, misery, trouble sleeping, chills, and craving, and reversed large decreases in food intake. Importantly, these therapeutic effects occurred at doses that were subjectively indistinguishable from placebo, meaning patients did not feel high.

In contrast, divalproex (1500 mg/day) decreased marijuana craving during abstinence but increased anxiety, irritability, and tiredness, worsened cognitive performance, and increased food intake regardless of marijuana condition. The authors concluded that oral THC but not divalproex may be useful for treating marijuana dependence.

Why it matters

This was an early demonstration of the concept of agonist replacement therapy for cannabis dependence, analogous to methadone for opioid dependence or nicotine replacement for tobacco. The finding that oral THC could relieve withdrawal without intoxication suggested a practical clinical approach to cannabis dependence treatment.

The numbers in context

Seven participants per study. 6-10 marijuana cigarettes per day at baseline. Oral THC: 10 mg five times daily. Divalproex: 1500 mg/day. THC reduced craving without intoxication; divalproex reduced craving but worsened mood and cognition.

How the study worked

Two placebo-controlled, within-subject studies. Study 1 (n=7): 15-day inpatient/5-day outpatient/15-day inpatient design testing oral THC (10 mg, 5x daily) during marijuana abstinence. Study 2 (n=7): 58-day outpatient/inpatient design testing divalproex (1500 mg/day). Participants smoked 6-10 joints daily and were not seeking treatment.

What this study cannot tell us

Very small samples (7 per study) in a controlled laboratory setting. Participants were not seeking treatment, which may limit applicability to treatment-seeking populations. The short abstinence periods may not capture the full withdrawal trajectory.

How to read the evidence

This is a placebo-controlled within-subject study with rigorous inpatient methodology, though limited by very small samples of 7 per study.

When this study was published

Published in 2004. Dronabinol has been further studied for cannabis dependence in larger trials since.

The bigger picture

The concept of using oral THC for cannabis withdrawal management has been further studied, and dronabinol has been tested in larger clinical trials for cannabis dependence. While not yet a standard treatment, the agonist replacement approach remains one of the most promising pharmacological strategies for cannabis use disorder.

Questions still open

Would oral THC work as a long-term tapering agent for cannabis dependence? How does this approach compare to behavioral treatments? Could newer oral cannabinoid formulations improve upon these results?

Common questions

Can THC pills help you quit marijuana?

This study showed that oral THC capsules reduced withdrawal symptoms like anxiety, insomnia, and craving without making people feel high. It is similar to how nicotine patches help people quit smoking by providing the drug in a controlled form without the harmful delivery method.

Is marijuana withdrawal real?

Yes. This study documented withdrawal symptoms including irritability, anxiety, misery, muscle pain, chills, sleep problems, and decreased appetite in heavy daily users who stopped. These symptoms were measurable and responded to oral THC treatment.

Read the original research

Marijuana withdrawal in humans: effects of oral THC or divalproex.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 29(1), 158-70

View on PubMed ↗

Citation

Haney, Margaret; Hart, Carl L; Vosburg, Suzanne K; Nasser, Jennifer; Bennett, Andrew; Zubaran, Carlos; Foltin, Richard W. (2004). Marijuana withdrawal in humans: effects of oral THC or divalproex.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 29(1), 158-70.